抗真菌药物市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003745
  • Category : Pharmaceuticals
  • No. of Pages : 169
Buy Now

Antifungal Drugs Market Insights and Growth by 2031

Buy Now

全球抗真菌药物市场预计将从 2021 年的 111.353 亿美元增长到2031年为139.974亿美元;预计 2022 年至 2031 年复合年增长率为 3.3%。

抗真菌药物用于治疗常见的真菌感染,例如出现在身体外表面的真菌指甲感染和阴道感染以及发生在身体组织内部或内部器官的其他真菌侵袭性感染例如肺和大脑。它通过杀死真菌细胞或限制其生长来对抗真菌感染。

抗真菌药物市场归因于真菌感染患病率不断上升;癌症、艾滋病毒和医院获得性感染的发病率增加;以及政府打击抗真菌疾病的有利举措。然而,对真菌感染缺乏认识正在阻碍市场的增长。

抗真菌药物市场根据感染类型、药物类型、治疗适应症、剂型和地理位置进行细分。该报告对抗真菌药物市场进行了深入的洞察和分析,重点介绍了市场趋势、技术进步和市场动态等各种参数,以及主要市场参与者的竞争格局分析。

战略见解

抗真菌药物市场利润丰厚的区域

Antifungal Drugs Market市场洞察

真菌感染患病率上升促进抗真菌药物市场增长

真菌感染主要是由微小真菌引起的,这种真菌常见于大气中。根据美国疾病控制与预防中心 (CDC) 的数据,2013 年至 2017 年,美国真菌感染的平均发病率为每 10 万人中约 9 例。念珠菌血症是美国最常见的血液感染之一。 CDC 预测全国每年约有 25,000 例念珠菌血症病例。不同年龄组的念珠菌血症发生率存在显着差异。婴儿的发病率大大降低。 65 岁以上人群的念珠菌血症发病率主要较高。念珠菌血症发病率的差异是由于年龄、种族、基础环境改变、社会经济地位和其他因素造成的。

而且,由于南亚气候热带,真菌感染的频率很高。例如,根据 Down To Earth 组织 2015 年发布的一份报告,美国 1,000 名患者中酵母菌感染率为 0.8。此外,欧洲和澳大利亚的发病率分别为每 1000 名患者 0.2 例和 0.9 例。然而,在印度,每 1,000 名真菌感染患者中大约就有 1-12 例感染。因此,由于提供有助于维持患者适当免疫力的治疗,对抗真菌药物的需求不断增加。因此,真菌感染病例的增加可能会在未来几年推动抗真菌药物市场的发展。

基于感染类型的见解

根据感染类型,全球抗真菌药物市场分为浅表真菌感染和全身抗真菌感染。 2021年,浅表真菌感染领域占据了较大的市场份额,预计在预测期内也将以最快的速度增长。皮肤、指甲和头发真菌感染患病率的上升可能会在预测期内促进抗真菌药物市场的增长。

抗真菌药物市场,按类型划分2021 年和 2031 年

 

Antifungal Drugs Market

基于药物类型的见解

根据药物类型,全球抗真菌药物市场分为棘白属、唑类、多烯类、烯丙胺类等。 2021年,唑类细分市场占据最大市场份额。然而,预计多烯细分市场在预测期内将以最快的速度增长。

基于治疗适应症的见解

根据治疗适应症,全球抗真菌药物市场分为曲霉菌病、皮肤癣菌病、念珠菌病等。 2021年,念珠菌病细分市场占据最大市场份额。然而,皮肤癣菌病部分预计在未来几年将以最快的速度增长。

基于剂型的见解

根据剂型,全球抗真菌药物市场分为药品、软膏剂、粉剂等。 2021年,药品细分市场占据最大市场份额,预计未来几年将以最快的速度增长。

亚太地区抗真菌药物市场预计在预测期内将以最快的速度增长。由于中国、日本和印度等国家制药业的不断发展,预计该市场在预测期内将会增长。中国医药工业是全球最大的医药工业之一。该国在活性药物成分制造、竞争力、创新和最终剂型方面显示出显着增长。因此,大多数跨国公司都对中国药品销售市场表现出了兴趣。

2021年,北美占据抗真菌药物市场最大份额。以美国、加拿大、墨西哥三大国家为研究对象,研究北美抗真菌药物市场。该地区市场的增长主要得益于各国真菌感染病例的增加以及“真菌病宣传周”等宣传活动的不断开展。此外,由于真菌病患病率不断上升,预计墨西哥在未来几年将提供一些增长机会。例如,根据 2021 年《巴西传染病杂志》发表的一篇文章,墨西哥每年有超过 150 万人受到侵袭性真菌感染的影响。

按地理位置,抗真菌药物市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太地区其他地区)、中东和非洲非洲(阿联酋、沙特阿拉伯、非洲以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

公司简介

  • < span style="font-size: 10pt; font-family: verdana、geneva、sans-serif;">辉瑞公司
  • 赛诺菲 SA
  • 吉利德科学公司
  • 默克公司, Inc.
  • Synexis 公司
  • 诺华国际股份公司
  • 雅培实验室
  • 拜耳公司
  • 格兰马克制药
  • 葛兰素史克公司。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

  1. Pfizer Inc.
  2. Sanofi S.A.
  3. Gilead Sciences, Inc.
  4. Merck And Co., Inc.
  5. Scynexis Inc.
  6. Novartis International AG
  7. Abbott Laboratories
  8. Bayer AG
  9. Glenmark Pharmaceutical
  10. Glaxosmithkline Plc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..